LRPAP1
Reaktivität: Human
WB, IHC, ICC
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
IHC: 1:50 - 1:100
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
Lot specific
Buffer
Supplied as antiserum with 0.09 % NaN3.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
Handhabung
Avoid repeated freeze/thaw cycles
Lagerung
-20 °C
Informationen zur Lagerung
Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
Wang, Subramanian, Lu, Howatt, Moorleghen, Charnigo, Cassis, Daugherty: "Deficiency of receptor-associated protein attenuates angiotensin II-induced atherosclerosis in hypercholesterolemic mice without influencing abdominal aortic aneurysms." in: Atherosclerosis, Vol. 220, Issue 2, pp. 375-80, (2012) (PubMed).
Target
LRPAP1
(Low Density Lipoprotein Receptor-Related Protein Associated Protein 1 (LRPAP1))